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Abstract
Objective.—To describe the feasibility of a meaning-centered group psychotherapy (MCGP) 
adaptation in a sample of Portuguese cancer patients.
Method.—The study was carried out according to four steps: 1st — Transcultural adaptation and 
validation (focus groups); 2nd — Preliminary study with MCGP original version (to test its 
feasibility); 3rd — Adaptation of MCGP original version to a 4-session version (and internal pilot 
study); and 4th — Pilot exploratory trial (MCGP-4 session version), implemented between 
January 1, 2018 and December 31, 2019. Inclusion criteria were >18 years, psychological 
complaints, and difficulty to adapt to cancer. Allocation was according to participants’ preference: 
MCGP vs. care as usual (CAU). Primary outcomes were: MCGP adapted version improved quality 
of life (QoL) and spiritual well-being; secondary outcomes were improvement of depression, 
anxiety, and distress. Assessments were done at baseline (T1) and 1 month after (T2), with self-
report socio-demographic and clinical questionnaires, Distress Thermometer (DT), McGill Quality 
of Life Questionnaire (MQOL), Functional Assessment of Chronic Illness Therapy — Spiritual 
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Well-Being Scale (FACIT-Sp-12), Hospital Anxiety and Depression Scale, and its subscales 
(HADS — HADS-D, HADS-A).
Results.—In the 1st step, and through focus groups, the manual was reformulated and tested. 
The preliminary study (2nd step) with MCGP original version showed a high number of dropouts 
which could jeopardize the study and, after reframing the sessions content, MCGP was adapted to 
a 4-session version, and its feasibility was tested by an internal pilot study (3rd step). The pilot 
exploratory trial (4th step) had 91 participants. Most socio-demographic and clinical 
characteristics between the groups (51: MCGP; 40: CAU) had no statistically significant 
differences. A comparison between the two groups at T2 showed that the MCGP group scored 
significantly higher in the general (U = 552.00, P < 0.001), and existential (U = 727.50, P = 0.018) 
domains and total score (U = 717.50, P = 0.015) of QoL, and CAU presented statistical higher 
levels in DT (U = 608.50, P = 0.001). Comparing the groups between T1 and T2, the MCGP group 
had a statistically significant improvement in the general (Z = −3.67, P < 0.001) and psychosocial 
(Z = −2.89, P = 0.004) domains and total score (Z = −2.71, P = 0.007) of QoL, and a statistically 
significant decrease in DT (Z = −2.40, P = 0.016). In terms of group effects, the MCGP group 
presented increased general (b = 1.42, P < 0.001, ηp2 = 0.179), and support (b = 0.80, P = 0.045, 
ηp2 = 0.048) domains and total score (b = 0.81, P = 0.013, ηp2 = 0.073) of QoL (small to elevated 
dimensions), and decreased levels of depression (b = −1.14, P = 0.044, ηp2 = 0.048), and distress (b 
= −1.38, P = 0.001, ηp2 = 0.127) (small to medium dimensions), compared with CAU. At T2, 
participants who attended ≥3 sessions (n = 38) had a statistically significant higher score in the 
general domain (U = 130.50, P = 0.009) of QoL, comparing with those who attended 1 or 2 
sessions (n = 13).
Significance of results.—This study supports the benefits of an MCGP adapted version in 
improving QoL and psychologic well-being. More studies are necessary to address the limitations 
of this pilot exploratory trial, as its small sample size.
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Introduction
Spiritual well-being and a sense of meaning are important influences for quality of life 
(QoL) in patients with advanced cancer (Field and Cassel, 1997; Sinclair et al., 2006).
The importance of the existential care lead to the emergence of meaning-focused 
interventions (Breitbart, 2002; Chochinov et al., 2005; Puchalski, 2013) in advanced cancer 
patients or terminally ill (Yalom and Greaves, 1977; Spiegel et al., 1981; Edelman et al., 
1999; Edmonds et al., 1999; Classen et al., 2001; Kissane et al., 2003, 2007; Lee et al., 
2006; Breitbart et al., 2010; Chochinov et al., 2011). In response to this need, Breitbart and 
his investigation group developed meaning-centered psychotherapy (MCP) to help patients 
with advanced cancer sustain or enhance a sense of meaning and purpose in their lives, even 
as they approach the end of life (Breitbart, 2000, 2002; Greenstein and Breitbart, 2000; 
Breitbart et al., 2010, 2015; Van der Spek et al., 2013; Applebaum et al., 2015). MCP was 
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first developed in a group format (meaning-centered group psychotherapy — MCGP), which 
is a manualized eight-week intervention (each session: 1.5 h) that utilizes a combination of 
didactics, experiential exercises and discussion (Breitbart, 2002). The first randomized 
control trial (RCT) showed benefits in enhancing spiritual well-being and a sense of 
meaning (Breitbart et al., 2010). Further studies suggested that more severe forms of despair 
respond better to existential interventions (Breitbart et al., 2015).
The goal of this study is to describe the feasibility of an MCGP adaptation in a sample of 
Portuguese cancer patients. The outcomes were: MCGP adapted version improves QoL and 




This study was implemented according to four steps. Transcultural adaptation and validation 
of MCGP standardized manual to the Portuguese language was carried out through focus 
groups (1st step). The preliminary study with the original version of MCGP (2nd step) 
revealed a high number of dropouts, which could jeopardize the study, and led to the 3rd 
step — adaptation of MCGP original version to a 4-session version (maintaining the same 
periodicity and duration of the original version), and internal pilot study (to test its 
feasibility), which followed the same methodology as the 4th step, except regarding the care 
as usual (CAU) group. A pilot exploratory trial (4th step — Figure 1) had two arms, 
according to allocation criteria: MCGP vs. CAU. MCGP was led by a therapist (psychiatrist) 
and attended by another health professional for training purposes, and after participants’ 
consent.
It was carried out two assessments (T1 — MCGP: before the 1st session vs. CAU: 1st 
moment; T2 — MCGP: after the last session vs. CAU: 1 month after T1) with socio-
demographic and clinical questionnaires and self-report instruments to measure QoL, 
spiritual, and psychological well-being: Distress Thermometer (DT; Ouakinin et al., 2015; 
National Comprehensive Cancer Network, 2017), McGill Quality of Life Questionnaire 
(MQOL; Cohen et al., 1997; Duarte et al., 2010), Functional Assessment of Chronic Illness 
Therapy — Spiritual Well-Being Scale (FACIT-Sp-12; FACIT Group, 2011; Pereira and 
Santos, 2011), and Hospital Anxiety and Depression Scale (HADS; subscales: depression 
[HADS-D] and anxiety [HADS-A]; Zigmond and Snaith, 1983; Pais-Ribeiro et al., 2007). 
After each session, the therapist completed “Checklist of therapist adherence,” a self-report 
to assess if the goals of each session were achieved (Breitbart and Poppito, 2014).
Participants
Participants with cancer were recruited at a district hospital (Centro Hospitalar Barreiro-
Montijo) and two cancer associations (Portuguese League Against Cancer and Algarve 
Cancer Association) in Portugal, between January 1, 2018 and December 31, 2019. To 
ensure reliability, the inclusion criteria of this convenience sample (>18 years, psychological 
complaints, as depressed mood and anxiety, and difficulty to adapt to cancer) satisfied the 
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following assumptions: to replicate previous methodologies; to consist in a formal indication 
for existential psychotherapies (Teixeira, 2006; Breitbart and Alici, 2014; Julião, 2014; Van 
der Spek et al., 2014; Van Lankveld et al., 2018); and to use Hierarchical Taxonomy of 
Psychopathology (HiTOP) — a dimensional psychopathological classification (Kotov et al., 
2017; Conway et al., 2019) — to facilitate symptoms recognition by the recruiters (medical 
oncologists and psychologists). The authors assumed that screening of distress it would not 
be a good measure to inclusion criteria, as high levels of distress do not necessarily 
correspond to maladaptive responses, as these are determined by a complex process of 
mental adjustment (Moyer et al., 2009; Croy, 2010; Van Lankveld et al., 2018). Exclusion 
criteria were: cognitive deficits that interfere in the capacity to give informed consent, 
psychotic symptoms or substance abuse (Julião, 2014). The allocation was according to 
participants preference to be included in MCGP vs. CAU (Applebaum et al., 2012). The 
participants were contacted, within 1 month after having expressed their availability, when it 
was reached a minimum of 5 per group (Applebaum et al., 2012), and it was considered 
dropout when they participate in less than 3 sessions (this cut-off ensures the “same dose” of 
treatment, it is the ideal to verify differences in the outcomes keeping and, at the same time, 
maintain a conservative approach) (Breitbart et al., 2015). For participants with current 
psychiatric/psychologic follow-up, their therapists were informed.
MCGP has no known risks, and its structure provides space for participants personal 
feedback (Breitbart and Poppito, 2014). The study was approved by the Institutional Ethical 
Committees, and the Portuguese National Commission of Data Protection, in accordance 
with the principles embodied in the Declaration of Helsinki.
Statistical analysis
For the internal pilot study (3rd step) and the checklist of therapist adherence, it was 
performed a descriptive analysis. For the pilot exploratory trial (4th step), it was carried out 
a sample characterization, using descriptive analyses and chi-square test. For group 
comparisons, parametric and nonparametric tests were used (Wilcoxon test, Mann–Whitney, 
and Student’s t-tests). Analysis of group effects in primary and secondary outcomes used 
ANCOVA (independent variables: MCGP and CAU; dependent variables: 2nd assessment; 
covariate: 1st assessment; six covariables were identified to control possible confounding 
influences — age, gender, cancer stage, current chemotherapy [CT] treatments, personal 
psychiatric history, and current follow-up). Primary outcomes were QoL (MQOL total score 
and all domains) and spiritual well-being (FACIT total score and both dimensions). 
Secondary outcomes were depression (HADS-D), anxiety (HADS-A), and distress (DT). 
ANCOVA analysis demonstrated homogeneous variances for all variables; the assumption of 
slope homogeneity showed that there was not significant interaction between each dependent 
variable and the covariate, except for the support domain of QdV (P = 0.022). The groups 
had a similar dimension, so ANCOVA was robust to the analysis of these assumptions. The 
effect dimension was calculated using partial eta2 ([ηp2]; small effect size: ηp2 = 0.01, medium: 
ηp2 = 0.06, high: ηp2 = 0.14). Also, it was done a comparison analysis (T1 and T2) of spiritual 
and psychological between the participants who attended 1 or 2 sessions and those who 
attended 3 or all sessions.
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Intent to treat analysis was performed, and missing values were inputted according to the 
expectation–maximization method. Analysis used SPSS, version 25, and values P < 0.05 
was considered statistically significant.
Results
1st step: Transcultural adaptation and validation
Transcultural adaptation and validation was performed by four focus groups, led by the 
therapist, to evaluate the manual comprehensibility (Goes, 2007; Pasquali, 2009; Epstein et 
al., 2015; Medeiros et al., 2015). The first two focus groups discussed the manual content 
(1st group: cancer patients; 2nd: mental health professionals without experience in MCP), 
and the results were discussed in the 3rd group, constituted by experts. The findings showed 
the necessity to clarify some of MCP core concepts (Figure 2), which seemed culturally 
determined and independent from the educational level (Da Ponte et al., 2017). The 
manual’s reformulation was tested in another focus group, with cancer patients, and it was 
verified the substantial improvement of its comprehensibility.
2nd step: Preliminary study (MCGP original version — 8 sessions)
Of the initial sample (n = 11), six dropped out (the main reason was time consumption by 
the hospital, at the expense of participants’ personal life), and the majority of these did not 
complete the 2nd assessment.
3rd step: Adaptation of MCGP original version to a 4-session version (and internal pilot 
study)
Because of dropouts in the preliminary study that could jeopardized the investigation, and 
after consulting previous adaptations of MCGP to different settings (Breitbart et al., 2010, 
2012, 2015, 2018; Van der Spek et al., 2014, 2016; Lichtenthal et al., 2015; Rosenfeld et al., 
2017), the participantś preference for some themes (in the first steps of the study), and 
discussing with the author, MCGP was adapted to a 4-session version (Table 1). This 
consisted of a combination of sessions 1 and 2 (“Moments with Meaning” and “Cancer and 
Meaning”) and sessions 5, 6, and 7 (Attitudinal, Creative, and Experiential Sources of 
Meaning) of the original version in single sessions (respectively); similarly to the original 
version, and because of its importance described in previous studies, “Historical Sources of 
Meaning” occupied an entire session (Breitbart et al., 2010, 2012, 2015, 2018; Van der Spek 
et al., 2014, 2016; Lichtenthal et al., 2015; Rosenfeld et al., 2017). Based on therapist 
training in MCP and available support material (Memorial Sloan Kettering Cancer Center, 
2016), it was designed a short manual with the goals and exercises of each session, which 
conserved the same structure as MCGP original version: after a brief presentation of the 
therapist and the participants (session 1), session’s themes were presented, experiential 
exercises were distributed and participants were asked to write their answers; the remaining 
time consisted of didactic discussions and participants’ feedback.
Of the initial sample (n = 15), one-third of participants dropped out. The findings showed 
improvements in spiritual well-being (FACIT-Sp-12 total score: T1 — 32.54 vs. T2 — 
33.77; FACIT-Sp-12 dimension meaning/peace: T1 — 32.54 vs. T2 — 33.77), levels of 
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depression (HADS-D: T1 — 6.5 vs. T2 — 2.6), anxiety (HADS-A: T1 — 8.67 vs. T2 — 
6.2), distress (DT: T1 — 4.56 vs. T2 — 3.75), and QoL (MQOL total score: T1 — 6.18 vs. 
T2 — 6.99; MQOL existential domain: T1 — 6.87 vs. T2 — 7.91).
4th step: Pilot exploratory trial (MCGP-4 session version)
Sample description—Socio-demographic and clinical characteristics of the sample are 
represented in Table 2. Of the 91 participants, 51 (56%) participated in MCGP and 40 (44%) 
in CAU. The mean age of the sample was 61.04 years (SD: ±11.42; MCGP: 59.57; CAU: 
62.93), and the majority was female, married, and retired. In terms of clinical characteristics, 
breast cancer was the most frequent (MCGP: 51% vs. CAU: 70.0%), as it was the located 
stage (74.5% vs. 60%); most of participants were submitted to surgical (72.5% vs. 92.5%) 
and CT (64.7% vs. 82.5%) treatments and had physical comorbidities (62.7% vs. 60.0%). 
Although most of socio-demographic and clinical characteristics between the groups had no 
statistically significant differences, a more significant proportion of MCGP participants lived 
in a rural area and a lesser proportion lived in the suburbs of Lisbon, compared with CAU 
(48.9% vs. 7.9%; 35.6% vs. 71.1%, χ2 = 18.85, P < 0.001); fewer proportion of MCGP 
participants had done surgery, comparing with CAU (72.5% vs. 92.5%, χ2 = 5.87, P = 
0.015), and a higher proportion of MCGP participants had personal psychiatric history 
(62.7% vs. 37.5%, χ2 = 5.72, P = 0.017), and current follow-up (60.8% vs. 35.0%, χ2 = 
5.96, P = 0.015), comparing with CAU. Of the participants that were not on current follow-
up, there was a significantly higher percentage of MCGP participants that considered it 
would be beneficial (82.4% vs. 50.0%, χ2 = 4.71, P = 0.030), comparing with CAU.
Group comparison and group effects—The comparison between groups (Table 3) in 
T1 showed that there was statistically significant differences in the psychosocial domain of 
QoL (mean: MCGP: 4.83 vs. CAU: 6.70; U = 566.90, P < 0.001) and anxiety (mean: 
MCGP: 9.33 vs. CAU: 7.00; U = 646.00, P = 0.003), where the MCGP group scored 
significantly lower in the psychosocial domain of QoL, and higher in anxiety, comparing 
with the CAU group. At T2, there was statistically significant differences between the 
general (mean: MCGP: 7.08 vs. CAU: 5.95; U = 552.00, P < 0.001), physical (mean: 
MCGP: 5.93 vs. CAU: 5.26; U = 731.50, P = 0.018) and existential (mean: MCGP: 6.98 vs. 
CAU: 6.57; U = 727.50, P = 0.018) domains and the total score (mean: MCGP: 6.64 vs. 
CAU: 6.24; U = 717.50, P = 0.015) of QoL, and anxiety (mean: MCGP: 8.66 vs. CAU: 7.31; 
U = 740.50, P = 0.023), where the MCGP group scored significantly higher. On the other 
hand, the CAU group presented statistical higher levels in DT (mean: MCGP: 4.32 vs. CAU: 
5.69; U = 608.50, P = 0.001), in comparison with the MCGP group. Comparing the groups 
between T1 and T2, for the MCGP group, there was a statistically significant improvement 
in the general (mean: T1: 5.45 vs. T2: 7.08; Z = −3.67, P < 0.001) and psychosocial (mean: 
T1: 4.83 vs. T2: 6.20; Z = −2.89, P = 0.004) domains and total score (mean: T1: 5.88 vs. T2: 
6.64; Z = −2.71, P = 0.007) of QoL, and a statistically significant decrease in DT (mean: T1: 
5.28 vs. T2: 4.32; Z = −2.40, P = 0.016). In the CAU group, there was a significant statistical 
decrease in the support domain (mean: T1: 6.14 vs. T2: 5.69; Z = −2.18, P = 0.029) of QoL 
and a significant statistical increase in DT (mean: T1: 4.81 vs. T2: 5.69; Z = 02.44, P = 
0.015).
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ANCOVA analysis (Table 4) tested group effects in QoL, spiritual well-being, anxiety, 
depression, and distress, after controlling for the scores in T1, as well as age, gender, cancer 
stage, CT treatments, and personal psychiatric history. For QoL and spiritual well-being, 
after accounting for the covariables effects, general, and support domains and the total score 
of QoL were significantly influenced by the group (group effect with small to elevated 
dimensions), where the MCGP group, compared with the CAU group, had an increase in 
general (b = 1.42, P < 0.001, ηp2 = 0.179), and support (b = 0.80, P = .045, ηp2 = 0.048) 
domains and total score (b = 0.81, P = 0.013, ηp2 = 0.073) of QoL. For spiritual well-being, 
there was not an improvement in the MCGP group, comparing with the CAU group. For 
depression, anxiety and distress, after taking into account the covariables effect, it was found 
significant differences in the variables depression and distress, with an improvement 
(decrease) in levels of depression (b = −1.14, P = 0.044, ηp2 = 0.048) and distress (b = −1.38, 
P = 0.001, ηp2 = 0.127) in the MCGP group, in comparison with the CAU group. These results 
had small to medium dimension effects.
Attrition rate—The attrition rate was 25.5% (13 dropouts), and the main reasons were 
illness and appointments (n = 3, 23.1%, respectively). In T1, participants that frequented 1 
or 2 sessions (n = 13) had a statistically significant higher score in FACIT total score (U = 
128.50, P = 0.010), and its dimension faith (U = 123.50, P = 0.007), comparing with those 
participants that frequented ≥3 sessions (n = 38). In T2, those participants that frequented ≥3 
sessions had a statistically significative higher score in the general domain of QoL (U = 
130.00, p = 0.009), comparing with those that frequented less sessions.
Checklist of therapist adherence—The therapist was less adherent to session 3 (mean: 
5.75; minimum: 4; maximum: 7), comparing all sessions. The main reason was the difficulty 
of accomplishing all the goals of the session’ themes (Attitudinal, Creative, and Experiential 
Sources of Meaning), namely the exercises related to “Experiential Sources of Meaning.”
Discussion
MCGP transcultural adaptation and validation showed that existential themes, particularly 
“sources of meaning” or “transcendence,” raised questions culturally determined and related 
to the “meaning of life” (Hambleton and Patsula, 1990; Swaine-Verdier et al., 2004; Goes, 
2007; Pasquali, 2009; Epstein et al., 2015; Medeiros et al., 2015; Da Ponte et al., 2017). The 
high number of dropouts verified with MCGP original version is well described in previous 
studies that reported the link between the limitations of psychosocial research in cancer 
patients and personal time-consumption by medical care (Croy, 2010; Applebaum et al., 
2012). The internal pilot study using MCGP adapted version supported its feasibility and 
possible positive benefits in QoL and spiritual and psychological well-being.
Many socio-demographic and clinical characteristics between MCGP and CAU had not 
statistically significant differences, which supports the sample’s homogeneity. Although a 
higher proportion of MCGP participants had personal psychiatric history and current follow-
up, these variables were controlled by statistical analysis. On the other hand, the smaller 
proportion of MCGP participants submitted to surgery gives to this group a lower theoretical 
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risk of psychopathology (McFarland et al., 2019), but this result needs to be integrated with 
the rest, namely the number of participants in question (MCGP: 37/51 vs. CAU = 37/40).
The group comparison in the 1st assessment showed that MCGP, compared with the CAU 
group, presented a reduction of QoL, in its psychosocial domain, and higher levels of 
anxiety. In the 2nd assessment, the MCGP group, compared with the CAU group, presented 
higher QoL in its general, physical and existential domains and total score, and, although it 
was not statistically significant, an improvement in the psychosocial domain of QoL (mean: 
T1: 4.83 vs. T2: 6.20). Similarly, the result of higher levels of anxiety in MCGP, comparing 
with the CAU group, needs to be integrated in the improvement (not statistically significant) 
of its levels (mean: T1: 9.33 vs. T2: 8.66). The group comparison between assessments 
supports the previous findings, as the MCGP group presented better QoL in its general and 
psychosocial domains and total score. The new finding of higher levels of distress in the 
MCGP group, comparing with the CAU group, give additional evidence of its benefit in this 
dimension of psychological well-being.
In terms of group effects, for the primary outcome (MCGP adapted version improves QoL 
and spiritual well-being), it was verified a group effect, with small to high dimensions, in 
which the MCGP group, compared with the CAU group, presented a higher QoL (general 
and support domains, and total score), but not for spiritual well-being. This last data needs to 
be integrated in former results, namely the mean values of FACIT, and its dimension 
meaning/peace, at baseline (and also in 2nd assessment), which could mean that there was 
little space for improvement (MCGP: FACIT total score — T1: 28.48 vs. T2: 27.82; 
dimension meaning/peace — T1: 18.11 vs. T2: 18.40; FACIT Group, 2011). For the 
secondary outcome (MCGP adapted version improves levels of depression, anxiety, and 
distress), it was verified a group effect, with small to medium dimensions, in which the 
MCGP group improved levels of depression and distress, supporting the former results of 
group comparison.
It was also verified that participants who attended less sessions had better spiritual well-
being at the beginning and, therefore, less need for psychotherapy. The improvement in QoL 
after psychotherapy in participants who attend more sessions can support the benefit of 
MCGP in QoL.
In terms of limitations, our pilot exploratory trial did not consist of RCT but an efficacy 
study, which is considered the more appropriate to study psychosocial interventions, given 
that it ensures external validity (Croy, 2010). The small sample, its cultural characteristics, 
and the adaptation in a short version of MCGP, could have conditioned the absence of its 
proven benefit in spiritual well-being. It is well described the relation between the benefit 
and duration of psychotherapies (Spiegel, 1978; Spiegel et al., 1981). Our recruitment rate 
was only possible by the expansion of inclusion criteria and allocation method — the first 
limitation was overpassed by our methodology (replication of previous studies) and 
statistical analysis (control of confounding variables) (Van Lankveld et al., 2018). The 
absence of screening for distress at the baseline was admitted, but it followed the assumption 
that high levels of distress do not necessarily correspond to maladaptive responses, as it is 
not the intensity but the nature of distress that determines the response (Moyer et al., 2009; 
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Croy, 2010; Van Lankveld et al., 2018). The second limitation — allocation according to 
participants’ preference — was also considered, given its relation with prognosis (Deeks et 
al., 2003). Although this, former studies gave strength to the intervention’s efficacy, pointing 
to the inconsistency between participants’ preference and attrition (Applebaum et al., 2012).
The reduction of the number of sessions in this adapted version could represent an advantage 
in terms of attrition rate (25.5%), taking into account that studies using MGCP original 
version showed rates between 25.8% and 56.9% (Applebaum et al., 2012; Breitbart et al., 
2015).
The checklist of the therapist’s adherence revealed his difficulty in adhering to all of session 
3 goals, namely the completion of exercises. To overpass this limitation, the authors suggest 
dividing this session into two.
In conclusion, the preliminary results gave evidence for the benefits of the MCGP adapted 
version in increasing QoL and psychological well-being. The authors believe that there is 
space to improve the consistency of this study, with a reformulation of the MCGP adapted 
version and a larger sample.
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Pilot exploratory trial (aintent to treat analysis; bMCGP: before the 1st session/ CAU: 1st 
moment; cMCGP: after the last session/CAU: 1 month after T1; DT, distress thermometer; 
FACIT-Sp-12, functional assessment of chronic illness therapy — spiritual well-being scale; 
HADS, hospital anxiety and depression scale; MCGP, meaning-centered group 
psychotherapy).
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